Arcus Biosciences, Inc. RCUS
18.80 USD +0.13 (+0.70%)
At closeNov 12, 2026, 7:03 AM EST
18.95 +0.15 +0.80%
Pre-market · Nov 12, 7:03 AM ET
18.54 Day range 18.90
17.43 52-week range 31.74
- YTD
- -21.11%
- 1 year
- -7.34%
RCUS revenue history
Revenue is income from the company’s ordinary business activities.
247,000,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 247,000,000 | -11,000,000 | -4.26% |
| FY 2024 | 2024-12-31 | 258,000,000 | 141,000,000 | 120.51% |
| FY 2023 | 2023-12-31 | 117,000,000 | 5,000,000 | 4.46% |
| FY 2022 | 2022-12-31 | 112,000,000 | -271,000,000 | -70.76% |
| FY 2021 | 2021-12-31 | 383,000,000 | 305,000,000 | 391.03% |
| FY 2020 | 2020-12-31 | 78,000,000 | 63,000,000 | 420.00% |
| FY 2019 | 2019-12-31 | 15,000,000 | 6,647,000 | 79.58% |
| FY 2018 | 2018-12-31 | 8,353,000 | 6,940,000 | 491.15% |
| FY 2017 | 2017-12-31 | 1,413,000 | 1,413,000 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:01:54.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.